Big Pharma digs its claws deeper into academia under guise of research
• naturalnews.comBecause the company has been unable to develop a steady stream of new "blockbuster" drugs on its own, London-based pharmaceutical giant AstraZeneca has decided to expand its corporate reach by essentially merging itself with the publicly-funded acade